Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000947871-01-500924
Filing Date
2001-11-01
Accepted
2001-11-01 00:00:00
Documents
3
Group Members
ORBIMED ADVISORS INC.ORBIMED ADVISORS LLC.SAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G s13g110101_isaly-triangle.txt SC 13G 8499
3 JOINT FILING AGREEMENT ex1-1_isaly110101.txt EX-1.1 1897
4 STATEMENT OF CONTROL PERSON ex2-1_isaly110101.txt EX-2.1 935
  Complete submission text file 0000947871-01-500924.txt   13099
Mailing Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-47359 | Film No.: 1772642
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address 787 THIRD AVE NEW YORK NY 10010 2127396400
ISALY SAMUEL D (Filed by) CIK: 0001055949 (see all company filings)